-
-
-
-
-
-
-
Eisai submits application for LEQEMBI IQLIK as starting dose for Alzheimer's
-
-
-
-
-
-
-
Mineralys Therapeutics Announces Pricing of $175.0 Million Underwritten Public Offering of Common Stock
-
-
-
22,605 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


